NASP

NASP Verified Subrogation Data

Retrieved on: 
Vendredi, août 19, 2022

These groups are falsely using the name of NASP (National Association of Subrogation Professionals) without permission and erroneously citing NASP as the source.

Key Points: 
  • These groups are falsely using the name of NASP (National Association of Subrogation Professionals) without permission and erroneously citing NASP as the source.
  • The data is false and does not represent true metrics of the subrogation industry.
  • NASP Benchmarking reports are a trusted source of accurate and timely subrogation data.
  • NASP Benchmarking reports are a trusted source of accurate and timely subrogation data.

Cornerstone Health Solutions Announces New Name and Brand

Retrieved on: 
Mercredi, août 10, 2022

BOSTON, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Cornerstone Health Solutions, an industry leader who builds and strengthens specialty pharmacy accelerator programs for hospitals and health systems, announced today that it has completed a major rebranding to become Clearway Health.

Key Points: 
  • BOSTON, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Cornerstone Health Solutions, an industry leader who builds and strengthens specialty pharmacy accelerator programs for hospitals and health systems, announced today that it has completed a major rebranding to become Clearway Health.
  • "Clearway Health's beginning at Boston Medical Center Health System is a legacy unlike any other in our industry," said Nicole Faucher, President.
  • The specialty pharmacy programs that Clearway Health creates and leads for our clients are defined by experiences and results that are proven.
  • Now, Clearway Health serves hospitals, health systems and the communities of patients they care for - providing a service that's been proven, lived and experienced by our team.

Riverside Insights to Host Evalu8 Continuing Ed Virtual Conference for Clinical Practitioners August 8-12

Retrieved on: 
Mardi, juillet 26, 2022

ITASCA, Ill., July 26, 2022 /PRNewswire-PRWeb/ -- Riverside Insights®, a leading developer of research-based assessments and analytics, today announced a week-long virtual conference for clinical practitioners to learn key assessment best practices, while earning valuable continuing education credits as they prepare for the fall influx of evaluations.

Key Points: 
  • "As we prepare for a new school year, Riverside Insights has been listening to practitioners and identified a number of important topics that are top-of-mind for evaluators," said Rajib Roy, CEO of Riverside Insights.
  • "With our Evalu8 conference, we have developed a program that brings together industry leaders, academic experts, and practitioners for a week of valuable learning that underscores our commitment to support each child's unique learning by empowering them to unlock their full potential."
  • The weeklong virtual conference offers two hours each day of dedicated professional learning with a specific topical focus.
  • To register for these free sessions, visit the Riverside Insights website at https://info.riversideinsights.com/evalu8 .

NASP Releases Agenda for its 2022 Annual Meeting & Expo and 10th Anniversary Celebration

Retrieved on: 
Mercredi, juillet 13, 2022

Washington, DC, July 13, 2022 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is pleased to announce the full agenda for the NASP 2022 Annual Meeting & Expo and 10th Anniversary Celebration.

Key Points: 
  • Washington, DC, July 13, 2022 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is pleased to announce the full agenda for the NASP 2022 Annual Meeting & Expo and 10th Anniversary Celebration.
  • The conference and all festivities surrounding NASPs anniversary will take place September 19 - 22, 2022 at the Gaylord Palms Resort & Convention Center in Orlando, FL.
  • NASP is a 501(c)(6) nonprofit trade organization and is the only national association representing all stakeholders in the specialty pharmacy industry.
  • With more than 160 corporate members and 2,700 individual members, NASP is the unified voice of specialty pharmacy in the United States

PANTHERx® Rare Announces Partnership with Biocodex for the Distribution of DIACOMIT® (stiripentol) for the Treatment of Seizures Associated with Dravet Syndrome in Patients 2 Years of Age and Older Taking Clobazam

Retrieved on: 
Lundi, juin 27, 2022

DIACOMIT is a new molecular entity approved by the FDA in 2018 for the adjunctive treatment of seizures associated with Dravet syndrome in those 2 years of age and older taking clobazam.

Key Points: 
  • DIACOMIT is a new molecular entity approved by the FDA in 2018 for the adjunctive treatment of seizures associated with Dravet syndrome in those 2 years of age and older taking clobazam.
  • Dravet syndrome is a lifelong disorder that can be associated with severe complications and decreased quality of life.
  • The seizures associated with Dravet syndrome are often considered difficult to treat requiring patients to try multiple antiseizure medications.
  • Our partnership will allow the Dravet syndrome community renewed hope for improved health outcomes," said Rob Snyder, President of PANTHERx.

FTC Advances Study Into PBM Practices and Impact on Specialty Pharmacies

Retrieved on: 
Mardi, juin 7, 2022

The study is expected to review PBM use of specialty drug lists, specialty drug policies, and other practices that limit specialty pharmacy networks and steer specialty patients and drugs away from those specialty pharmacies that are not otherwise owned or affiliated by a PBM or their vertically integrated partners.

Key Points: 
  • The study is expected to review PBM use of specialty drug lists, specialty drug policies, and other practices that limit specialty pharmacy networks and steer specialty patients and drugs away from those specialty pharmacies that are not otherwise owned or affiliated by a PBM or their vertically integrated partners.
  • NASP President and CEO Sheila Arquette, RPh stated, This study has been a long time coming, and today it feels like the collective voice of non-affiliated specialty pharmacies is beginning to be heard.
  • Clawbacks on pharmacies and other significant reimbursement limitations, patient steering, and deliberate efforts to preclude pharmacies from specialty pharmacy network participation must be addressed.
  • The National Association of Specialty Pharmacy (NASP) is the only national association representing all stakeholders in the specialty pharmacy industry.

PANTHERx Rare Celebrates Fifth Patient Choice Award Win

Retrieved on: 
Mercredi, mai 4, 2022

PITTSBURGH, May 4, 2022 /PRNewswire/ -- For a fifth time, PANTHERx Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award.

Key Points: 
  • PITTSBURGH, May 4, 2022 /PRNewswire/ -- For a fifth time, PANTHERx Rare has been recognized as the winner of the annual, Specialty Pharmacy Patient Choice Award.
  • Since 2016, the Managed Markets Insights & Technology Zitter Health Insight's (MMIT ZHI) Patient Choice Award has honored the winning specialty pharmacy's exemplary commitment to patients.
  • For a fifth time, the MMIT ZHI Patient Choice Award has validated this philosophy that those of us at PANTHERx always knew to be true," said PANTHERx President, Rob Snyder.
  • PANTHERx is now a five-time winner of the prestigious MMIT Patient Choice Award, including the 2022 honor.

NASP Thanks Biden Administration for Reducing Out-of-Pocket Drug Costs for Seniors and Taking Initial Steps to Address Pharmacy DIR Fees

Retrieved on: 
Lundi, mai 2, 2022

Arquette stated, CMS has taken a major step forward toward reducing senior drug costs through some needed pharmacy DIR reforms.

Key Points: 
  • Arquette stated, CMS has taken a major step forward toward reducing senior drug costs through some needed pharmacy DIR reforms.
  • Failure to address all retroactive fees could limit patient access to their pharmacy of choice and negatively impact pharmacy market competition.
  • The National Association of Specialty Pharmacy (NASP) is the only national association representing all stakeholders in the specialty pharmacy industry.
  • With over 150 corporate members and 2,500 individual members, NASP is the unified voice of specialty pharmacy in the United States.

POLYN Technology Delivers NASP Test Chip for Tiny AI

Retrieved on: 
Mercredi, avril 13, 2022

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220413005171/en/
    The POLYN Technology Neuromorphic Analog Signal Processor (NASP) chip is designed to mimic the way the human brain perceives and learns.
  • (Photo: Business Wire)
    POLYN Technology is an innovative provider of ultra-low-power-performance NASP technology and a producer of unique Tiny AI chips and their associated IP.
  • The NASP chip enables full data processing disaggregation between the sensor node and the cloud; it truly embodies the Tiny AI concept.
  • POLYN Technology is a fabless semiconductor company, supplying ultra-low-power, high-performance Neuromorphic Analog Signal Processing (NASP) technology, IP and Tiny AI chips based on NASP.

New Technology Increases Subrogation Recoveries and Keeps Insurance Rates Lower

Retrieved on: 
Jeudi, mars 31, 2022

In the automobile insurance industry, this translates to lost revenues as well as higher premiums for good drivers.

Key Points: 
  • In the automobile insurance industry, this translates to lost revenues as well as higher premiums for good drivers.
  • To do this, SubroCheck reads the text of insurance claims and performs a fact extraction over 150 different facts are extracted in all.
  • P&C Insurance companies are well aware of the missed subrogation problem, but have so far been unable to address it except by extensive (and costly) manual review.
  • Brian Howard, the marketing manager at Megaputer, discussed the impact this solution will have for insurers; Subrogation is a competitive game.